SCOPUS 정보 검색 플랫폼

Lupus

Volumn 23, Issue 2, 2014, Pages 201-203

Subacute lupus erythematosus during treatment with golimumab for seronegative rheumatoid arthritis

(3) Brunasso, Amg a Aberer, W a Massone, C a

a MEDICAL UNIVERSITY OF GRAZ (Austria)

Author keywords

adalimumab; autoimmunity; etanercept; Golimumab; infliximab; lupus erythematosus; rheumatoid arthritis; TNF

Indexed keywords

ANTINUCLEAR ANTIBODY; CORTISONE; ETANERCEPT; GOLIMUMAB; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MOMETASONE FUROATE; PREDNISONE;

ADULT; ANTIBODY TITER; ARM; ARTICLE; BACK; CASE REPORT; CORTICOSTEROID THERAPY; DRUG RESPONSE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; GENERAL CONDITION DETERIORATION; HUMAN; HUMAN TISSUE; JOINT SWELLING; KERATINOCYTE; MIDDLE AGED; PRIORITY JOURNAL; PROTECTION; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN DEFECT; SKIN LUPUS ERYTHEMATOSUS; SUBCUTANEOUS IMMUNOTHERAPY; SUN EXPOSURE; TOPICAL TREATMENT; TRUNK;

ADALIMUMAB; AUTOIMMUNITY; ETANERCEPT; GOLIMUMAB; INFLIXIMAB; LUPUS ERYTHEMATOSUS; RHEUMATOID ARTHRITIS; TNF-Α;

ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MIDDLE AGED;

EID: 84892569102 PISSN: 09612033 EISSN: 14770962 Source Type: Journal
DOI: 10.1177/0961203313517153 Document Type: Article

Times cited : (19)

References (13)

1
- 0013374274
- American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines
- American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Arthritis Rheum. 1999 ; 42: 1785-1796
- (1999) Arthritis Rheum , vol.42 , pp. 1785-1796

2
- 0034619028
- Adverse drug reactions: Definitions, diagnosis, and management
- Edwards IR, Aronson JK. Adverse drug reactions: Definitions, diagnosis, and management. Lancet. 2000 ; 356: 1255-1259
- (2000) Lancet , vol.356 , pp. 1255-1259
- Edwards, I.R.¹ Aronson, J.K.²

3
- 2442433545
- Clarifying adverse drug events: A clinician's guide to terminology, documentation, and reporting
- Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med. 2004 ; 140: 795-801
- (2004) Ann Intern Med , vol.140 , pp. 795-801
- Nebeker, J.R.¹ Barach, P.² Samore, M.H.³

4
- 84892599011
- Naranjo Algorithm, 16 June 2003 (accessed 16 October 2013)
- Naranjo Algorithm, 16 June 2003. Available at: http://qmweb.dads.state. tx.us/MedSim/Naranjo.htm (accessed 16 October 2013).

5
- 79955003756
- TNF alpha antagonist-induced lupus-like syndrome: Report and review of the literature with implications for treatment with alternative TNF alpha antagonists
- Williams VL, Cohen PR. TNF alpha antagonist-induced lupus-like syndrome: Report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Int J Dermatol. 2011 ; 50: 619-625
- (2011) Int J Dermatol , vol.50 , pp. 619-625
- Williams, V.L.¹ Cohen, P.R.²

6
- 21744446004
- Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: A French national survey
- De Bandt M, Sibilia J, Le Loët X, et al. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: A French national survey. Arthritis Res Ther. 2005 ; 7: R545 - R551
- (2005) Arthritis Res Ther , vol.7
- De Bandt, M.¹ Sibilia, J.² Le Loët, X.³

7
- 44349171691
- Drug-induced lupus due to anti-tumor necrosis factor alpha agents
- Costa MF, Said NR, Zimmermann B. Drug-induced lupus due to anti-tumor necrosis factor alpha agents. Semin Arthritis Rheum. 2008 ; 37: 381-387
- (2008) Semin Arthritis Rheum , vol.37 , pp. 381-387
- Costa, M.F.¹ Said, N.R.² Zimmermann, B.³

8
- 84867641228
- Golimumab-exacerbated subacute cutaneous lupus erythematosus
- Wilkerson E, Hazey MA, Bahrami S, Callen JP. Golimumab-exacerbated subacute cutaneous lupus erythematosus. Arch Dermatol. 2012 ; 148: 1186-1190
- (2012) Arch Dermatol , vol.148 , pp. 1186-1190
- Wilkerson, E.¹ Ma, H.² Bahrami, S.³ Callen, J.P.⁴

9
- 72149112759
- Autoimmune diseases induced by biological agents: A double-edged sword?
- Ramos-Casals M, Roberto-Perez-Alvarez, Diaz-Lagares C, Cuadrado MJ, Khamashta MA. Autoimmune diseases induced by biological agents: A double-edged sword?. Autoimmun Rev. 2010 ; 9: 188-1893
- (2010) Autoimmun Rev , vol.9 , pp. 188-1893
- Ramos-Casals, M.¹ Roberto-Perez-Alvarez² Diaz-Lagares, C.³ Cuadrado, M.J.⁴ Khamashta, M.A.⁵

10
- 79955003756
- TNF alpha antagonist-induced lupus-like syndrome: Report and review of the literature with implications for treatment with alternative TNF alpha antagonists
- Williams VL, Cohen PR. TNF alpha antagonist-induced lupus-like syndrome: Report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Int J Dermatol. 2011 ; 50: 619-625
- (2011) Int J Dermatol , vol.50 , pp. 619-625
- Williams, V.L.¹ Cohen, P.R.²

11
- 79952403189
- A systematic review of drug-induced subacute cutaneous lupus erythematosus
- Lowe G, Henderson CL, Grau RH, Hansen CB, Sontheimer RD. A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 2011 ; 164: 465-472
- (2011) Br J Dermatol , vol.164 , pp. 465-472
- Lowe, G.¹ Henderson, C.L.² Grau, R.H.³ Hansen, C.B.⁴ Sontheimer, R.D.⁵

12
- 78751496653
- Tolerability and safety of biological therapies for psoriasis in daily clinical practice: A study of 103 Italian patients
- Brunasso AM, Puntoni M, Salvini C, Delfino, et al. Tolerability and safety of biological therapies for psoriasis in daily clinical practice: A study of 103 Italian patients. Acta Derm Venereol. 2011 ; 91: 44-49
- (2011) Acta Derm Venereol , vol.91 , pp. 44-49
- Brunasso, A.M.¹ Puntoni, M.² Salvini, C.³ Delfino⁴

13
- 14044260093
- Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)
- Ledingham J, Deighton C. Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology (Oxford). 2005 ; 44: 157-163
- (2005) Rheumatology (Oxford) , vol.44 , pp. 157-163
- Ledingham, J.¹ Deighton, C.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.